Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Amphotericin B for Non-dermatophyte Onychomycosis
NCT03814343Phase 4Completed
- Sponsor
- Mahidol University
- Start
- Jan 2019
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of amphotericin b in onychomycosis (2 arms), sponsored by Mahidol University. Primary endpoints: Effectiveness (Mycological Cure) at 36 weeks and Median Time to Mycological Cure at 36 weeks. Started Jan 2019; status: completed.
02
Drugs
amphotericin b
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT03814343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03814343.